People: Life Technologies Corp (LIFE.OQ)
74.24USD
17 Jun 2013
$0.08 (+0.11%)
$74.16
$74.24
$74.25
$74.11
418,555
781,709
$74.48
$40.56
Andrews, Ronnie
Brief Biography
Mr. Ronnie A. Andrews is President - Medical Sciences of Life Technologies Corp., since February 02, 2012. From 2010 – 2012, Mr. Andrews served as Chief Executive Officer for the Clarient Business Unit, and Segment Leader in Molecular Diagnostics, for GE Healthcare. From 2004 until GE’s acquisition of the company, he served as Chief Executive Officer and Vice Chairman of Clarient Healthcare. Prior to joining Clarient, Mr. Andrews served in a variety of leadership roles at Roche Molecular Diagnostics, Immucor and Abbott Diagnostics. He received his B.S. in Biology and Chemistry from Wofford College.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 972,457 | -- | 1,674,780 | 3,947,190 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Gregory Lucier |
10,268,400 |
Mark Stevenson |
5,295,160 |
David Hoffmeister |
2,676,640 |
Ronnie Andrews |
3,947,190 |
Peter Leddy |
1,887,930 |
Kelli Richard |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
